Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome

Sa1158 The Number of Drug Side Effects Is Associated With Greater Efficacy in IBS Clinical Trials: The Potential Influence of Unblinding

(2015) Andres Ardila Hani et al.   GASTROENTEROLOGY

Effects of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation: A Meta-analysis

(2013) Elizabeth J. Videlock et al.   Clinical Gastroenterology and Hepatology

Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care

(2013) Alexander C. Ford et al.   GASTROENTEROLOGY

An evaluation of the FDA Responder Endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials

(2013) J. E. MacDougall et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints

(2012) E. M. M. Quigley et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

(2012) William D Chey et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

(2012) Satish Rao et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Evaluation of Harm in the Pharmacotherapy of Irritable Bowel Syndrome

(2012) Eric Shah et al.   AMERICAN JOURNAL OF MEDICINE

Peripheral Mechanisms in Irritable Bowel Syndrome

(2012) Michael Camilleri   NEW ENGLAND JOURNAL OF MEDICINE

Irritable bowel syndrome

(2012) A. C. Ford et al.   BMJ-British Medical Journal

IBS Patients Show Frequent Fluctuations Between Loose/Watery and Hard/Lumpy Stools: Implications for Treatment

(2011) Olafur S Palsson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

(2011) Stacy B Menees et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation

(2010) J. F. JOHANSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome

(2010) H. VAHEDI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evaluating a Bacterial Hypothesis in IBS Using a Modification of Koch’s Postulates: Part 1

(2010) Mark Pimentel   AMERICAN JOURNAL OF GASTROENTEROLOGY

Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation

(2010) Jeffrey M. Johnston et al.   GASTROENTEROLOGY

Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective

(2010) James H Lewis   Expert Review of Gastroenterology & Hepatology

Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

(2009) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies

(2008) D. A. DROSSMAN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response

(2008) Anthony Lembo et al.   GASTROENTEROLOGY

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

(2008) A C Ford et al.   GUT